FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2584582525> ?p ?o ?g. }

• W2584582525 endingPage "188" @default.
• W2584582525 startingPage "182" @default.
• W2584582525 abstract "BackgroundRadical local treatment of pulmonary metastases is practiced with increasing frequency due to acknowledgment and better understanding of oligo-metastatic disease. This study aimed to develop a nomogram predicting overall survival (OS) after stereotactic body radiotherapy (SBRT) for pulmonary metastases.Patients and methodsA multi-institutional database of 670 patients treated with SBRT for pulmonary metastases was used as training cohort. Cox regression analysis with bidirectional variable elimination was performed to identify factors to be included into the nomogram model to predict 2-year OS. The calibration rate of the nomogram was assessed by plotting the actual Kaplan–Meier 2-year OS against the nomogram predicted survival. The nomogram was externally validated using two separate monocentric databases of 145 and 92 patients treated with SBRT for pulmonary metastases.ResultsThe median follow up of the trainings cohort was 14.3 months, the 2-year and 5-year OS was 52.6% and 23.7%, respectively. Karnofsky performance index, type of the primary tumor, control of the primary tumor, maximum diameter of the largest treated metastasis and number of metastases (1 versus >1) were significant prognostic factors in the Cox model (all p < 0.05). The calculated concordance-index for the nomogram was 0.73 (concordance indexes of all prognostic factors between 0.54 and 0.6). Based on the nomogram the training cohort was divided into 4 groups and 2-year OS ranged between 24.2% and 76.1% (predicted OS between 30.2% and 78.4%). The nomogram discriminated between risk groups in the two validation cohorts (concordance index 0.68 and 0.67).ConclusionsA nomogram for prediction of OS after SBRT for pulmonary metastases was generated and externally validated. This tool might be helpful for interdisciplinary discussion and evaluation of local and systemic treatment options in the oligo-metastatic setting.Key messageA nomogram for prediction of overall survival after stereotactic body radiotherapy (SBRT) for pulmonary metastases was developed and externally validated. This tool might be helpful for interdisciplinary discussion and evaluation of local and systemic treatment options in the oligo-metastatic setting." @default.
• W2584582525 created "2017-02-10" @default.
• W2584582525 creator A5005687748 @default.
• W2584582525 creator A5006806306 @default.
• W2584582525 creator A5008555900 @default.
• W2584582525 creator A5010325047 @default.
• W2584582525 creator A5014432039 @default.
• W2584582525 creator A5018591118 @default.
• W2584582525 creator A5019373452 @default.
• W2584582525 creator A5023510680 @default.
• W2584582525 creator A5027718042 @default.
• W2584582525 creator A5032037681 @default.
• W2584582525 creator A5038338085 @default.
• W2584582525 creator A5039229070 @default.
• W2584582525 creator A5039691793 @default.
• W2584582525 creator A5042272207 @default.
• W2584582525 creator A5044179041 @default.
• W2584582525 creator A5046756579 @default.
• W2584582525 creator A5046979273 @default.
• W2584582525 creator A5048585327 @default.
• W2584582525 creator A5053943773 @default.
• W2584582525 creator A5054903967 @default.
• W2584582525 creator A5055289994 @default.
• W2584582525 creator A5059493220 @default.
• W2584582525 creator A5060267032 @default.
• W2584582525 creator A5060509370 @default.
• W2584582525 creator A5064008006 @default.
• W2584582525 creator A5069002225 @default.
• W2584582525 creator A5070051122 @default.
• W2584582525 creator A5072040768 @default.
• W2584582525 creator A5079287119 @default.
• W2584582525 creator A5091641647 @default.
• W2584582525 date "2017-05-01" @default.
• W2584582525 modified "2023-09-27" @default.
• W2584582525 title "Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease" @default.
• W2584582525 cites W1528207664 @default.
• W2584582525 cites W1919216911 @default.
• W2584582525 cites W1969531640 @default.
• W2584582525 cites W2015003595 @default.
• W2584582525 cites W2024501410 @default.
• W2584582525 cites W2030505692 @default.
• W2584582525 cites W2031282907 @default.
• W2584582525 cites W2031688279 @default.
• W2584582525 cites W2049605916 @default.
• W2584582525 cites W2058697497 @default.
• W2584582525 cites W2060836405 @default.
• W2584582525 cites W2061285215 @default.
• W2584582525 cites W2073086268 @default.
• W2584582525 cites W2074113942 @default.
• W2584582525 cites W2077982938 @default.
• W2584582525 cites W2084470612 @default.
• W2584582525 cites W2105400743 @default.
• W2584582525 cites W2147100680 @default.
• W2584582525 cites W2158789700 @default.
• W2584582525 cites W2166459387 @default.
• W2584582525 cites W2171123343 @default.
• W2584582525 cites W2344871417 @default.
• W2584582525 cites W2527553935 @default.
• W2584582525 cites W2536769127 @default.
• W2584582525 cites W2591258896 @default.
• W2584582525 cites W4240340450 @default.
• W2584582525 cites W4249552602 @default.
• W2584582525 doi "https://doi.org/10.1016/j.radonc.2017.01.003" @default.
• W2584582525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28169042" @default.
• W2584582525 hasPublicationYear "2017" @default.
• W2584582525 type Work @default.
• W2584582525 sameAs 2584582525 @default.
• W2584582525 citedByCount "51" @default.
• W2584582525 countsByYear W25845825252017 @default.
• W2584582525 countsByYear W25845825252018 @default.
• W2584582525 countsByYear W25845825252019 @default.
• W2584582525 countsByYear W25845825252020 @default.
• W2584582525 countsByYear W25845825252021 @default.
• W2584582525 countsByYear W25845825252022 @default.
• W2584582525 countsByYear W25845825252023 @default.
• W2584582525 crossrefType "journal-article" @default.
• W2584582525 hasAuthorship W2584582525A5005687748 @default.
• W2584582525 hasAuthorship W2584582525A5006806306 @default.
• W2584582525 hasAuthorship W2584582525A5008555900 @default.
• W2584582525 hasAuthorship W2584582525A5010325047 @default.
• W2584582525 hasAuthorship W2584582525A5014432039 @default.
• W2584582525 hasAuthorship W2584582525A5018591118 @default.
• W2584582525 hasAuthorship W2584582525A5019373452 @default.
• W2584582525 hasAuthorship W2584582525A5023510680 @default.
• W2584582525 hasAuthorship W2584582525A5027718042 @default.
• W2584582525 hasAuthorship W2584582525A5032037681 @default.
• W2584582525 hasAuthorship W2584582525A5038338085 @default.
• W2584582525 hasAuthorship W2584582525A5039229070 @default.
• W2584582525 hasAuthorship W2584582525A5039691793 @default.
• W2584582525 hasAuthorship W2584582525A5042272207 @default.
• W2584582525 hasAuthorship W2584582525A5044179041 @default.
• W2584582525 hasAuthorship W2584582525A5046756579 @default.
• W2584582525 hasAuthorship W2584582525A5046979273 @default.
• W2584582525 hasAuthorship W2584582525A5048585327 @default.
• W2584582525 hasAuthorship W2584582525A5053943773 @default.
• W2584582525 hasAuthorship W2584582525A5054903967 @default.
• W2584582525 hasAuthorship W2584582525A5055289994 @default.
• W2584582525 hasAuthorship W2584582525A5059493220 @default.

• next